MARY HIRE: Open Payments
NPI 1265629935 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 114 payments from 17 companies in 2025. Trend: 2023 $3,002 · 2024 $2,921 · 2025 $2,262
Food & beverage: $2,178Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $620 |
| Janssen Biotech, Inc. | 13 | $300 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $283 |
| Phathom Pharmaceuticals, Inc. | 11 | $212 |
| QOL Medical, LLC | 10 | $198 |
| GENZYME CORPORATION | 7 | $192 |
| Aimmune Therapeutics, Inc. | 4 | $96 |
| Lilly USA, LLC | 4 | $90 |
| Ipsen Biopharmaceuticals, Inc | 3 | $68 |
| Gilead Sciences, Inc. | 2 | $42 |
Products named: TREMFYA, LINZESS, VOQUEZNA, Sucraid, DUPIXENT, XIFAXAN, CREON, SKYRIZI.
Industry payments across LA — which companies pay providers there.
